| Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: Results of a prospective, randomized study. | |
| | |
MedLine Citation:
|
PMID: 23068088 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The optimal protocol for the detection and treatment of postthyroidectomy hypoparathyroidism is unknown. We sought to identify and treat patients at risk for symptomatic hypocalcemia on the basis of a single parathyroid hormone (PTH) obtained the morning after surgery (POD1). METHODS: We performed a prospective, randomized study of total thyroidectomy patients who had POD1 calcium and PTH (pg/mL) levels. Randomization was determined by POD1 PTH: if ≥10, patients received no supplementation unless symptomatic; if <10, patients were randomized to calcium, calcium and calcitriol, or no supplementation. RESULTS: Of 143 patients, 112 (78%) had a POD1 PTH ≥10. Hypocalcemic symptoms were transiently reported in 11 (10%) and managed with outpatient calcium. Of 31 patients with PTH <10, 15 (48%) developed symptoms, including 5 who required intravenous calcium. On multivariate logistic regression analysis, when we adjusted for postoperative calcium level and performance of central neck dissection, we found that predictors of hypocalcemic symptoms were younger age (odds ratio 1.59, 95% confidence interval 1.07-2.32) and a PTH <10 (odds ratio 1.08, 95% confidence interval 1.04-1.12). There were no patient or treatment-related factors that predicted a POD1 PTH <10. CONCLUSION: A single POD1 PTH level <10 can accurately identify those patients at risk for clinically significant hypocalcemia. All total thyroidectomy patients with a postoperative PTH ≥10 can be safely discharged without supplementation. Given the small number of patients with PTH <10, it is unclear whether both calcium and calcitriol are needed for these higher-risk patients. |
| | |
Authors:
|
Ashley K Cayo; Tina W F Yen; Sarah M Misustin; Kimberly Wall; Stuart D Wilson; Douglas B Evans; Tracy S Wang |
Related Documents
:
|
23678158 - Systemic sclerosis in canada's north american native population: assessment of clinical... 23270828 - Phlebosclerosis in lower extremities veins. 23676418 - Tumor marker and measurement fluctuations may not reflect treatment efficacy in patient... 23263868 - Lupus nephritis and non-hodgkin lymphoma simultaneously diagnosed in a patient on methi... 23678158 - Systemic sclerosis in canada's north american native population: assessment of clinical... 8961698 - Serum alpha 1 antitrypsin and pulmonary emphysema. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-13 |
Journal Detail:
|
Title: Surgery Volume: - ISSN: 1532-7361 ISO Abbreviation: Surgery Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0417347 Medline TA: Surgery Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Mosby, Inc. All rights reserved. |
Affiliation:
|
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Intrathyroidal parathyroid glands: Small, but mighty (a Napoleon phenomenon).
Next Document: Routine use of bioprosthetic mesh is not necessary: a retrospective review of 100 consecutive cases ...